Related MeSH Hierarchy (4)
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Esophageal Diseases » Esophagitis » Eosinophilic Esophagitis
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastroenteritis » Esophagitis » Eosinophilic Esophagitis
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Leukocyte Disorders » Eosinophilia » Eosinophilic Esophagitis
Diseases [C] » Immune System Diseases [C20] » Hypersensitivity » Hypersensitivity, Immediate » Eosinophilic Esophagitis
Description
Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens. MeSH
Hierarchy View
Phase 4 Indicated Drugs (6)
Phase 3 Indicated Drugs (5)
Phase 1 Indicated Drugs (7)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 2 Indications (33)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
